Table 2.
Statistical results
| n | Mean | Std. deviation | Min | Max | |
|---|---|---|---|---|---|
| RECIST analysis | |||||
| Partial response | 11 (64.7%) | ||||
| Stable disease | 5 (29.4%) | ||||
| Progressive disease | 1 (5.9%) | ||||
| Complete response (CR) | 0 (0%) | ||||
| No target lesion | 2 | ||||
| CA125 (IU/l) levels | |||||
| Pre-NACT | 23 | 2,725.49 | 7,292.59 | 171.1 | 35,757.0 |
| Post-NACT | 22 | 105.27 | 146.05 | 9.9 | 548.0 |
| Reduction (%) | 85.66% | 28.99% | − 40.83%* | 98.81% | |
| PCI | |||||
| Pre-NACT | 23 | 29.91 | 4,49 | 25 | 39 |
| Post-NACT | 23 | 12.65 | 10.17 | 0 | 29 |
| Reduction | 17.26 | 10.31 | 2 | 39 | |
*Negative reduction increase of CA125 level